Navigation Links
HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data

NEW BRUNSWICK, N.J., Jan. 4, 2012 /PRNewswire/ -- The HealthCare Institute of New Jersey (HINJ) today released key findings of its 2011 economic impact survey, which indicates that the life sciences continue to play a leading role in driving New Jersey's economy. For the eighth consecutive year, the study was conducted by Deloitte.

While the data reported shows a slowing of economic activity, it is important to note that the  2010 results included in the 2011 economic impact survey come from five fewer companies (19) compared to those who contributed the calendar year 2009 results (24), included in the 2010 economic impact survey, making year-to-year comparisons considerably less meaningful. Participation in the annual survey by HINJ member companies is voluntary and confidential.

"Although we had 20 percent fewer companies participating in this year's survey, those that did supply data demonstrate that the life sciences industry continues to be a major economic driver in New Jersey," said Dean J. Paranicas, HINJ's President and Chief Executive Officer. "However, New Jersey continues to face stiff competition from around the world and within the U.S. for our industry's investment. If anything, this data reinforces the need for our leaders in Trenton and Washington to continue to pursue policies that create a more competitive and attractive business climate here, and we look forward to continuing to work with them to achieve this objective."

Paranicas added that HINJ and its member companies applaud actions taken over the past several months by Governor Christie and the State Legislature to make New Jersey more competitive and attractive for life sciences investment. They include an aggressive and competitive business recruitment and retention program, adopting the single sales factor as the basis for calculating New Jersey's corporate business income tax, and enhancing the Business Employment Incentive Program (BEIP) to promote greater private sector collaboration with New Jersey's universities and colleges.

The HINJ findings showed a total economic impact from reporting HINJ member companies of $24.2 billion in calendar year 2010, as compared to $29.3 billion in calendar year 2009. Paranicas explained that this difference reflects fewer companies responding to the survey and may also be accounted for by  the continuing effects of the global recession and industry consolidation.  He also cited reduced capital spending (which is consistent with prevailing economic conditions) and reporting from less than all participants about industry spending with New Jersey-based vendors.

The reported number of full-time employees decreased from 55,366 to 51,619 for the same period, a 6.8 percent decline. Reported capital spending decreased to $0.7 billion in 2010, down from $1.5 billion in 2009, and the economic impact of reported vendor spending was $5.5 billion, down from $8.4 billion in 2009. Gifts to New Jersey non-profit organizations totaled $161 million, down from $214 million in 2009. Total taxes paid in  New Jersey declined to $731 million, from $773 million.

However, Paranicas  also observed that the data submitted by the 16 HINJ member companies that participated in both the 2010 and 2011 surveys shows that the economic impact of those companies was generally constant, at $23.9 billion in 2010 and $24.5 billion in calendar year 2009. Among this cohort, global research and development spending increased by $1.4 billion, to $8.4 billion, and charitable donations in New Jersey also increased 8.1 percent, to $159 million from $147 million.

Paranicas emphasized that there are major bright spots that bode well for future economic activity. Research and development spending in New Jersey was up by 11.4 percent, to $6.1 billion, and medical device trials conducted by reporting companies soared 49.1 percent. Paranicas further noted recent announcements made by HINJ members to expand in New Jersey, as well as by other life sciences companies who have announced they are relocating to, or expanding in, the state.

"We are continuing to see strong life sciences investment in the future and in New Jersey," said Paranicas.

The HealthCare Institute of New Jersey is the trade association for New Jersey's research-based biopharmaceutical and medical device companies. HINJ is providing these key findings from its survey and will release the full results early in 2012. To learn more about HINJ, please visit

As used in this document, "Deloitte" means Deloitte LLP and its subsidiaries.  Please see for a detailed description of the legal structure of Deloitte LLP and its subsidiaries.  Certain services may not be available to attest clients under the rules and regulations of public accounting.

Contact: Donald Sico

SOURCE HealthCare Institute of New Jersey
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
2. Mindray Medical to Attend Morgan Stanley Global Healthcare Unplugged Conference
3. TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm
4. Beckman Coulter to Present at the Thomas Weisel Healthcare Conference 2008
5. Beckman Coulter to Present at the Morgan Stanley Healthcare Unplugged Conference
6. 3SBio Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference
7. Neurocrine Biosciences to Present at Thomas Weisel Healthcare Conference and the NewsMakers in the Biotech Industry Conference
8. Oridion Expands its OEM Partnerships - New Agreement with Spacelabs Healthcare
9. Varian, Inc. to Present at Thomas Weisel Partners 2008 Healthcare Conference
10. Thermage, Inc. to Present at the 2008 Thomas Weisel Partners Healthcare Conference
11. Trubion Pharmaceuticals to Present at Fall 2008 Morgan Stanley Global Healthcare Unplugged Conference in New York
Post Your Comments:
(Date:12/1/2015)... , Dec. 1, 2015  CardioCell LLC, a ... stem cells for cardiovascular indications, intends to proceed ... based on recommendations from a Heart Failure Advisory ... Scientific Advisory Board members . In a ... Phase IIa safety and efficacy data from CardioCell,s ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... backed, age-defying products, is featured as the cover story and throughout Success ... unrivaled opportunities that Nerium provides. Success from Home magazine routinely features successful ...
(Date:12/1/2015)... -- Dr. Harry Lander , President of Regen, expands ... Science Officer and recruits five distinguished scientists to ... President of Regen, expands his role to include ... five distinguished scientists to join advisory team --> ... include serving as Chief Science Officer ...
(Date:12/1/2015)... , December 1, 2015 ... addition of the  "2016 U.K. Virology and ... Forecasts for 100 Tests, Supplier Shares by ...  report to their offering.  --> ... the  "2016 U.K. Virology and Bacteriology Testing ...
Breaking Biology Technology:
(Date:10/29/2015)... Calif. , Oct. 29, 2015  The J. ... new report titled, "DNA Synthesis and Biosecurity: Lessons Learned ... the Department of Health and Human Services guidance for ... in 2010. --> ... it also has the potential to pose unique biosecurity ...
(Date:10/29/2015)... , Oct. 29, 2015  Connected health pioneer, ... driving the explosion of technology-enabled health and wellness, and ... new book, The Internet of Healthy Things ... sensors or smartphones even existed, Dr. Kvedar, vice president, ... of health care delivery, moving care from the hospital ...
(Date:10/27/2015)... , Oct. 27, 2015 In the present ... of concern for various industry verticals such as banking, ... to the growing demand for secure & simplified access ... ,sectors, such as hacking of bank accounts, misuse of ... equipment such as PC,s, laptops, and smartphones are expected ...
Breaking Biology News(10 mins):